Bifurcation Warranted In Lotrel Patent Spat: Judge
A federal judge has agreed to bifurcate the trial in a patent infringement suit brought by Novartis AG to protect its hypertension drug Lotrel, writing that "the separation of issues would...To view the full article, register now.
Already a subscriber? Click here to view full article